Status:

NOT_YET_RECRUITING

Extracorporeal Shock Wave Versus Photobiomodulation Therapy for Chronic Ankle Instability

Lead Sponsor:

Cairo University

Conditions:

Chronic Ankle Instability, CAI

Eligibility:

All Genders

20-65 years

Phase:

NA

Brief Summary

PURPOSE: To Compare between the effect of extra corporeal shock wave and Photobiomodulation on pain level, ROM, muscle strength, function level, dynamic balance and thickness of ligament in patients ...

Detailed Description

The purpose of the study will be to investigate the effect of extracorporeal shock wave versus photobiomodulation therapy for chronic ankle instability Design of the study: A pre and posttest randomiz...

Eligibility Criteria

Inclusion

  • \- 60 participants ranging in age from 18 to 65 years from both gender with a diagnosis of Chronic lateral ankle instability stage (II) (Schurz et al., 2023).
  • Patients body mass index (BMI) are ranged from 18,5 to 25 (lee et al., 2022). The main presenting symptoms were ankle pain with restricted ROM that compromised activities of daily living (Schurz et al., 2023).
  • All ankle sprains occurring more than four weeks before inclusion both recurrent sprain and CAI patients are included (Schurz et al., 2023).
  • Mild to moderate severity of pain measured by NPRS scale (Srinivas, 2022). no wounds in the ankle joint and calf (lee et al., 2022). Participants had no history of ankle joint injuries or surgical procedures within the last year and injection treatment around the ankle joint within six months (lee et al., 2022).

Exclusion

  • they had any medical condition that could cause ankle pain (arthritis, fracture, rheumatiod arthritis, any deformity of ankle and neurological condition).
  • Any individual who had previously suffered a musculoskeletal injury or surgery that could have influenced the measurement was also eliminated.
  • Any individual who had diagnosed a Chronic lateral ankle instability stage (I, III).
  • Acute foot trauma occurring from 7 days of injury (Srinivas, 2022).

Key Trial Info

Start Date :

August 29 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 10 2026

Estimated Enrollment :

38 Patients enrolled

Trial Details

Trial ID

NCT07139288

Start Date

August 29 2025

End Date

January 10 2026

Last Update

August 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Faculty of Physical Therapy Cairo University

Giza, EL Dokki, Egypt